Revolutionizing Plastic Surgery: Unraveling the Therapeutic Potential of in Vitro Cultivated Human Keratinocytes for Enhanced Tissue Engineering and Regenerative Applications in Plastic Surgery
Main Article Content
Abstract
The advancement of regenerative medicine in the realm of plastic surgery has witnessed a paradigm shift with the advent of in vitro cultivated human keratinocytes. This groundbreaking research explores the dynamic landscape of these cultured keratinocytes, shedding light on their pivotal role in reshaping the landscape of reconstructive and plastic procedures.
This comprehensive investigation delves into the intricate cellular mechanisms and proliferative capacities of in vitro cultivated human keratinocytes, elucidating their potential applications in addressing cutaneous defects, scars, and other dermal imperfections. Notably, the utilization of these cultured cells presents a novel avenue for promoting wound healing, tissue regeneration, and enhancing overall outcomes in various plastic surgery interventions.
Moreover, the study investigates the feasibility of incorporating in vitro cultivated human keratinocytes into tissue-engineered constructs, emphasizing their role in bolstering the structural integrity of grafts and flaps. The integration of these cultured cells into the realm of plastic surgery not only holds promise for augmenting traditional approaches but also opens doors to innovative strategies for optimizing plastic outcomes.
This article further explores the safety and efficacy of incorporating in vitro cultivated human keratinocytes in diverse plastic surgery scenarios, ranging from facelifts to breast reconstruction. Insights gained from this research pave the way for a deeper understanding of the cellular dynamics involved, thereby facilitating the development of tailored approaches that harness the regenerative potential of these keratinocytes.
In conclusion, the integration of in vitro cultivated human keratinocytes into the landscape of plastic surgery represents a transformative leap forward. This research not only accentuates the scientific progress achieved in understanding the cellular intricacies but also underscores the potential of these cultured cells as a cornerstone in reshaping the future of regenerative medicine within the field of plastic surgery.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Cherry DK, Hing E, Woodwell DA, Rechtsteiner EA. National Ambulatory Medical Care Survey: 2006 summary. Natl Health Stat Rep 2008;1–39.
II. Pitts SR, Niska RW, Xu J, Burt CW. National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary. Natl Health Stat Rep 2008;1–38.]
III. Miller SF, Bessey P, Lentz CW, Jeng JC, Schurr M, Browning S. National burn repository 2007 report: a synopsis of the 2007 call for data. J Burn Care Res 2008;29:862–70; discussion 871. Discussion 71.
IV. Forjuoh SN. Burns in low- and middle-income countries: a review of available literature on descriptive epidemiology, risk factors, treatment, and prevention. Burns 2006;32:529–37.
V. Peck MD. Epidemiology of burns throughout the world. Part I: distribution and risk factors. Burns 2011;37:1087–100.
VI. Stewart IJ, Sosnov JA, Snow BDet al.. Hypertension after injury among burned combat veterans: a retrospective cohort study. Burns 2017;43:290–6.
VII. Kagan RJ, Peck MD, Ahrenholz DH, et al.. Surgical management of the burn wound and use of skin substitutes: an expert panel white paper. J Burn Care Res 2013;34:e60–79.
VIII. Magnusson M, Papini RP, Rea SM, Reed CC, Wood FM. Cultured autologous keratinocytes in suspension accelerate epithelial maturation in an in vivo wound model as measured by surface electrical capacitance. Plast Reconstr Surg 2007;119:495–9.
IX. Jackson D, Topley E, Cason JS, Lowbury EJ. Primary excision and grafting of large burns. Ann Surg 1960;152:167–89.
X. Holavanahalli RK, Helm PA, Kowalske KJ. Long-term outcomes in patients surviving large burns: the skin. J Burn Care Res 2010;31:631–9.
XI. Vyas KS, Vasconez HC. Wound healing: biologics, skin substitutes, biomembranes, and scaffolds. Healthcare. 2014;2:356–400.
XII. Davis JS. Skin transplantation. Johns Hopkins Hosp Rep 1910;15:307–96.
XIII. Skardal A, Murphy SV, Crowell K, Mack D, Atala A, Soker S. A tunable hydrogel system for long-term release of cell-secreted cytokines and bioprinted in situ wound cell delivery. J Biomed Mater Res B Appl Biomater 2017;105:1986–2000.
XIV. Kirsner RS, Bohn G, Driver VRet al.. Human acellular dermal wound matrix: evidence and experience. Int Wound J 2015;12:646–54.
XV. Martinez-De Jesús FR, Frykberg R, Zambrano-Loaiza E, Jude EB. Re-Epithelialization of Neuropathic Diabetic Foot Wounds with the Use of Cryopreserved Allografts of Human Epidermal Keratinocyte Cultures (Epifast). Journal of Clinical Medicine. 2022; 11(24):7348. https://doi.org/10.3390/jcm11247348
XVI. De-Luna-Gallardo, Daniel; Cahuana-Quispe, Alberto I1; García-Espinoza, Jaime A; Arámbula-Sánchez, Blanca Y; Navarro-Delgadillo, Carlos I; Dávila-Díaz, Rodrigo; Erazo-Franco, Mauricio A2; Costa-Dulche, Alejandro; Mena-Garza, Ana A2; Morales-De-La-Cerda, Rodrigo2; Flores-Soto, David; Cuervo-Vergara, Marco A; Reyes-Ibarra, Patricia Alma2; Márquez-Esrpiella, Cuahutémoc. Use of Cultivated Epidermal Allograft in Chronic Wounds: A Novel Therapeutic Alternative. Journal of Cutaneous and Aesthetic Surgery 15(3):p 237-243, Jul–Sep 2022. |
DOI: 10.4103/JCAS.JCAS_177_21